Executives
-
Graham Jonathan PEVP & Gen. Counsel & Secy. -
Khosla RachnaSVP, Business Development
-
Busch Matthew C.VP, Finance & CAO
-
Grygiel Nancy A.SVP & CCO
-
Santos EstebanEVP, Operations
-
Reese David MEVP & Chief Technology Officer
-
Miller DerekSVP, Human Resources
-
Griffith Peter H.EVP & CFO
-
Gordon MurdoEVP, Global Commercial Ops
-
Bradner James E.EVP, R&D, & Chief Sci. Officer
?
Holley Charles M
Director
Amgen Inc.
US, Thousand Oaks [HQ]
CIK
1216478
Data Source
We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.
Latest Information
Shares :
95,740,209
Price per Share :
$272.11
Equivalence :
$26,051,868,270.99
Transaction History
-
A95,740,209 Shares After TransactionValue : $n/a$0.0Transaction Date : 05/31/24
-
Footnotes
-
-
Footnotes:#1 The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case payment will occur according to the elected deferral schedule.#2 These shares include 912 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.
-
A97,768,079 Shares After TransactionValue : $n/a$0.0Transaction Date : 08/09/24
-
Footnotes
-
-
Footnotes:#1 The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case payment will occur according to the elected deferral schedule#2 These shares include 983 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.
-
A88,550,209 Shares After TransactionValue : $n/a$0.0Transaction Date : 05/07/24
-
Footnotes
-
-
Footnotes:#1 The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended (the Director Program), under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule.#2 These shares include 912 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.
-
A101,140,229 Shares After TransactionValue : $n/a$0.0Transaction Date : 11/04/24
-
Footnotes
-
-
Footnotes:#1 The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule.#2 These shares include 1,052 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.